Man Group’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$752K Sell
11,327
-147,082
-93% -$12.4M ﹤0.01% 1943
2026
Q1
$15.7M Buy
158,409
+62,745
+66% +$8.18M 0.03% 612
2025
Q4
$11.6M Sell
95,664
-17,892
-16% -$2.25M 0.02% 726
2025
Q3
$12.7M Buy
113,556
+88,914
+361% +$10.4M 0.02% 686
2025
Q2
$3.3M Buy
+24,642
New +$2.71M 0.01% 1238
2025
Q1
Sell
-395,447
Closed -$24.7M 2368
2024
Q4
$24.7M Buy
395,447
+50,127
+15% +$4.67M 0.06% 355
2024
Q3
$54.2M Buy
+345,320
New +$53.2M 0.14% 170
2023
Q3
Hold
0
1448
2022
Q2
Hold
0
1610
2021
Q4
Sell
-26,199
Closed -$867K 2108
2021
Q3
$867K Buy
26,199
+7,600
+41% +$232K ﹤0.01% 1374
2021
Q2
$617K Buy
+18,599
New +$515K ﹤0.01% 1504
2020
Q4
Sell
-15,400
Closed -$212K 1935
2020
Q3
$212K Buy
+15,400
New +$264K ﹤0.01% 1696

Other funds holding TMDX

Man Group's TMDX Position: Q2 2026 in Review

Man Group reduced its Transmedics (TMDX) stake by 93% in Q2 2026, selling an estimated $12.4M and leaving 11,327 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Man Group first reported a position in TMDX in Q3 2020 and has held it in 10 quarters since. The position peaked at $54.2M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Man Group held 11,327 shares of Transmedics worth $752K as of Q2 2026.
  • Man Group sold 147,082 Transmedics shares in Q2 2026, an estimated $12.4M.
  • Transmedics made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1943 holding.
  • Man Group first reported a position in Transmedics in Q3 2020 and has held it in 10 quarters since.
  • Man Group's Transmedics position peaked at $54.2M in Q3 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.